Foundation to Host Biomarker Qualification Workshop/Webcast, January 27-28
January 13, 2010
On January 27th and 28th in Bethesda, MD, the COPD Foundation, along with academic experts, pharmaceutical companies and the FDA, have designed a workshop that will focus on the scientific and clinical issues in the development and qualification of biomarkers for COPD.
The COPD Biomarkers Qualification Workshop will feature expert panels that will share data and engage in debates with workshop attendees, including individuals representing academic institutions, government entities and pharmaceutical companies. The workshop will result in a publication on the available data and data gaps for biomarker qualification, as well as the plan to formulate a consortia comprised of both public and private organizations dedicated to biomarker qualification.
Exciting developments in COPD research have made it clear to experts that validating biomarkers will improve drug discovery for COPD and allow clinicians to better diagnose COPD.
Individuals interested in participating via live webcast may obtain more information by contacting Jamie Lamson at . Please provide your contact information, current position and institution. Web links will be available the week of the workshop and will be sent to confirmed participants via email.